Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 78 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8697704

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  2. US 8697709

    Fused ring heteroaryl kinase inhibitors

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  3. US 8697628

    Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  4. US 8691868

    Neprilysin inhibitors

    Theravance, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  5. US 8691758

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  6. US 8691501

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  7. US 8691828

    Thienopyrimidine as CDC7 kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  8. US 8691831

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  9. US 8691852

    Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

    Amirall, S.A. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  10. US 8691184

    Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  11. US 8691848

    Inhibitors of caspases

    Vertex Pharmaceuticals Incorporated · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  12. US 8686143

    Compounds useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  13. US 8686010

    Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  14. US 8685936

    Sphingosine kinase inhibitor prodrugs

    Apogee Biotechnology Corporation · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  15. US 8685926

    Compositions and method for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  16. US 8686184

    Neprilysin inhibitors

    Theravance, Inc. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  17. US 8680046

    Inhibitors of viral integrase and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  18. US 8669081

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted

  19. US 8669249

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted

  20. US 8664251

    Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

    The Regents of the University of California · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  21. US 8664219

    Aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  22. US 8658669

    Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  23. US 8653070

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  24. US 8653088

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.